Bellis Perennis 1 X Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet is a Health Canada–registered human drug (DIN 02233094) held by Seroyal International Inc., containing Bellis Perennis. Health Canada lists its status as Cancelled Post Market (status date 06 Jul 2009). Nexara Health has matched 22 registrations of Bellis Perennis across 3 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02233094 |
|---|---|
| Brand name | Bellis Perennis |
| Active ingredient | Bellis Perennis |
| Strength | 1 X |
| Dosage form | Drops ; Globules ; Granules ; Liquid ; Pellet ; Tablet |
| Route | Oral |
| Company | Seroyal International Inc. |
| Status | Cancelled Post Market — 06 Jul 2009 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Bellis Perennis registered in other markets
22 registrations of the same molecule in 3 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Bestmade Natural Products Bellis Per | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| Netherlands | Bellis perennis | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Bellis perennis | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United Arab Emirates | Bellis Perennis - Boiron | BOIRON, France, Messimy | 1 DH - 200 CH | Pillules | Active | EDE |
| United States | Bellis perennis | Boiron | Pellet | listed | FDA NDC | |
| United States | Bellis perennis | Boiron | Pellet | listed | FDA NDC | |
| United States | Bellis perennis | Boiron | Pellet | listed | FDA NDC | |
| United States | Bellis perennis | Boiron | Pellet | listed | FDA NDC | |
| United States | Bellis perennis | Boiron | Pellet | listed | FDA NDC | |
| United States | Bellis perennis | Boiron | Pellet | listed | FDA NDC | |
| United States | Bellis perennis | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Bellis Perennis worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Bellis Perennis (DIN 02233094) marketed in Canada?
No. Health Canada lists DIN 02233094 as Cancelled Post Market as of 06 Jul 2009.
Who holds the Canadian licence for this product?
Seroyal International Inc. is the company of record in the Health Canada Drug Product Database.
Is Bellis Perennis registered outside Canada?
Yes — Nexara Health has matched 22 registrations in 3 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233094, status date 2009-07-06; national medicine registries: EDE, EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233094, status date 2009-07-06; national medicine registries: EDE, EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02233094, status date 2009-07-06; national medicine registries: EDE, EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.